A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer
Cell-free DNA’s (cfDNA) use as a biomarker in cancer is challenging due to genetic heterogeneity of malignancies and rarity of tumor-derived molecules. Here we describe and demonstrate a novel machine-learning...
20:820
BMC Cancer 2020
No hay comentarios:
Publicar un comentario